Langerhans cells are negative regulators of the anti-Leishmania response
Open Access
- 2 May 2011
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 208 (5), 885-891
- https://doi.org/10.1084/jem.20102318
Abstract
Langerhans cells suppress the immune response to low-dose Leishmania major infection in part by inducing regulatory T cells.Keywords
This publication has 30 references indexed in Scilit:
- Functional Redundancy of Langerhans Cells and Langerin+ Dermal Dendritic Cells in Contact HypersensitivityJournal of Investigative Dermatology, 2010
- CD207(+) CD103(+) dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cellsThe Journal of Experimental Medicine, 2010
- Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functionsProceedings of the National Academy of Sciences of the United States of America, 2009
- Insights into Langerhans cell function from Langerhans cell ablation modelsEuropean Journal of Immunology, 2008
- Identification of a novel population of Langerin+ dendritic cellsThe Journal of Experimental Medicine, 2007
- Blood-derived dermal langerin+ dendritic cells survey the skin in the steady stateThe Journal of Experimental Medicine, 2007
- The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cellsThe Journal of Experimental Medicine, 2007
- CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistenceThe Journal of Experimental Medicine, 2006
- Two waves of antigen‐containing dendritic cells in vivo in experimental Leishmania major infectionEuropean Journal of Immunology, 2004
- Interleukin 1α Promotes Th1 Differentiation and Inhibits Disease Progression in Leishmania major–susceptible BALB/c MiceThe Journal of Experimental Medicine, 2003